Skip to Main Content

Paper Details

SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.
J Clin Invest
81
2021
ACE2, AIDS, COVID-19, COVID-19 disease, CTSL, Cancer, FURIN, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 entry factors, SARS-CoV-2 viremia, participants
Author NameAffiliation
Kasidet ManakongtreecheepMassachusetts General Hospital, Harvard Medical School
Kasidet ManakongtreecheepBroad Institute of MIT and Harvard
Alexandra-Chloé VillaniMassachusetts General Hospital, Harvard Medical School
Alexandra-Chloé VillaniCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital
Alexandra-Chloé VillaniBroad Institute of MIT and Harvard
Nir HacohenMassachusetts General Hospital, Harvard Medical School
Nir HacohenCenter for Cancer Research
Nir HacohenBroad Institute of MIT and Harvard
Nir HacohenMassachusetts General Hospital, Harvard Medical School
Nir HacohenBroad Institute of MIT and Harvard
Nir HacohenCenter for Cancer Research
Michael R FilbinMassachusetts General Hospital, Harvard Medical School
Michael R FilbinBroad Institute of MIT and Harvard
  • 1 - 13

Datasets

Release 1.2